Anisodamine Critically Ill SeptIc Shock

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

355

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

October 31, 2020

Study Completion Date

October 1, 2020

Conditions
Septic Shock
Interventions
DRUG

anisodamine

Anisodamine will be given first as bolus of 10 mg, followed by 0.1-0.5mg/kg/hr. The adjustment of pump infusion rate is largely at the discretion of treating physician, with the aim of improving microcirculation and limit the side effect to a minimum. For example, if serum lactate continues to elevate, the infusion rate can be increased. Discontinuation on severe side effect or recovery of shock (normalized lactate, weaned from vasopressor) or death.

Trial Locations (15)

200001

department of critical care medicine, Ren Ji Hospital, School of medicine, Shanghai Jiao Tong University, Shanghai

210029

the First Affiliated Hospital of Nanjing Medical University, Nanjing

310000

Zhejiang Hospital, Hangzhou

317000

Taizhou hospital of Zhejiang province, Taizhou

321000

Sir Run Run Shaw hospital, Hangzhou

Jinhua Municipal Central Hospital, Jinhua

323000

Department of critical care medicine, The central hospital of Lishui City, Lishui

516000

Huizhou first hospital, Huizhou

Unknown

Union Hospital, Tongji medical collegue, Huazhong university of Science and Technology, Wuhan

affiliated hospital, Jiangsu University, Zhenjiang

Binzhou People's hospital of Shandong province, Binzhou

Peace hospital of Changzhi medical college, Changzhi

The first People's hospital of Yongkang, Guli

Sir Run Run Shaw hospital, Hangzhou

Beilun People's hospital; The first affiliated hospital of Zhejiang university (Beilun Branch), Ningbo

All Listed Sponsors
lead

Jinhua Central Hospital

OTHER

NCT02442440 - Anisodamine Critically Ill SeptIc Shock | Biotech Hunter | Biotech Hunter